Meet The Team Of NeurAsia
Dr Parim Singh
Chairman
MBBS, MRCP (Edin)
A UK-trained physician with over 40 years of clinical and governance experience, Dr Singh upholds NeurAsia’s commitment to scientific integrity and ethical excellence across all programs.
Dr Sud Agarwal
Chief Executive Officer
MB ChB, FANZCA, DDU
A recognized leader in clinical trial strategy and innovation, Dr Agarwal brings ASX and NASDAQ biotech expertise to NeurAsia’s global trial execution.
Dr Bhaveen Marne
Chief Medical Officer
MBBS (NZ), FRACR (AUS)
Dr Marne is a dual-trained radiologist and medical executive overseeing site medical operations, imaging protocols, and safety reviews.
Umeera Maan
Chief Financial
Officer
BAcc, CPA
Umeera drives group-level finance, tax strategy, and operational efficiency across NeurAsia’s multinational platform with a focus on R&D optimization.
Darryl Davies
Chief Operating Officer
BSc (Hons)
Darryl brings decades of CRO and biotech leadership from the UK and ANZ region, ensuring execution excellence and sponsor satisfaction across all sites.
Sheann Lee
Registered Pharmacist & Global IMP Manager
BPharm (Hons), GCP/GDP Certified
Sheann oversees NeurAsia’s IMP operations, including licensing, storage, and distribution of controlled substances across Asia-Pacific.
Amrit Marne
Medical Writer
BBusCom (Accounting & Banking)
Amrit contributes to the development of protocols, IBs, and trial documentation with structured clarity and regulatory alignment.